1,914 research outputs found
GRAIL, an omni-directional gravitational wave detector
A cryogenic spherical and omni-directional resonant-mass detector proposed by
the GRAIL collaboration is described.Comment: 5 pages, 4 figs., contribution to proceedings GW Data Analysis
Workshop, Paris, nov. 199
Clinical and radiological hip parameters do not precede, but develop simultaneously with cam morphology:a 5-year follow-up study
Measurement of mechanical vibrations excited in aluminium resonators by 0.6 GeV electrons
We present measurements of mechanical vibrations induced by 0.6 GeV electrons
impinging on cylindrical and spherical aluminium resonators. To monitor the
amplitude of the resonator's vibrational modes we used piezoelectric ceramic
sensors, calibrated by standard accelerometers. Calculations using the
thermo-acoustic conversion model, agree well with the experimental data, as
demonstrated by the specific variation of the excitation strengths with the
absorbed energy, and with the traversing particles' track positions. For the
first longitudinal mode of the cylindrical resonator we measured a conversion
factor of 7.4 +- 1.4 nm/J, confirming the model value of 10 nm/J. Also, for the
spherical resonator, we found the model values for the L=2 and L=1 mode
amplitudes to be consistent with our measurement. We thus have confirmed the
applicability of the model, and we note that calculations based on the model
have shown that next generation resonant mass gravitational wave detectors can
only be expected to reach their intended ultra high sensitivity if they will be
shielded by an appreciable amount of rock, where a veto detector can reduce the
background of remaining impinging cosmic rays effectively.Comment: Tex-Article with epsfile, 34 pages including 13 figures and 5 tables.
To be published in Rev. Scient. Instr., May 200
Інноваційна діяльність через впровадження технопарків
Досвід усього світу показує, що економічне зростання країн вже давно базується на
використанні сфери знань і високих технологій, а їх ефективне поєднання гарантує
прогресивний розвиток нації та людства. Однією з найбільш вдалих форм такої
інтеграції є технопарки.
Саме тому розвитку технопарків на сьогоднішній день приділяють увагу вчені та
економісти.
Основною метою статті є інноваційна діяльність через впровадження
технологічних парків, їх призначення та вплив на розвиток країни
Screening for BRCA2 mutations in 81 Dutch breast–ovarian cancer families
We have analysed 81 families with a history of breast and/or ovarian cancer for the presence of germline mutations in BRCA2 with a number of different mutation screening techniques. The protein truncation test (PTT) for exons 10 and 11 detected four different frame-shifting mutations in six of these families. Four of the remaining 75 families had given positive linkage evidence for being due to BRCA2. In these families the entire coding region was analysed by single-strand conformational polymorphism, leading to the detection of a non-sense and a splice-site mutation in two of them. While these studies were in progress, Southern analysis of BRCA1 revealed that in our study-population of 81 families, 15 families were segregating either the exon 13 or exon 22 deletion in BRCA1 (Petrij-Bosch et al (1997) Nat Genet17: 341–345). This prompted us to examine BRCA2 in the remaining 58 families by Southern analysis, using two different restriction enzymes. No aberrations were found in the restriction patterns. Thus, contrary to BRCA1, large genomic rearrangements within the BRCA2 gene do not represent a major mutation mechanism among Dutch breast cancer families. © 2000 Cancer Research Campaig
CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
BACKGROUND: Development of multiple primary tumors is a hallmark of hereditary cancer. At least 1/10 of breast cancers and colorectal cancers occur because of heredity and recently the cell cycle kinase 2, CHEK2 1100delC allele has been identified at a particularly high frequency in families with hereditary breast and colorectal cancer. METHODS: We utilized the Southern Sweden population-based cancer registry to identify women with double primary breast and colorectal cancer and sequenced tumor material in order to assess the contribution of the CHEK2 1100delC to the development of such metachronous tumors. RESULTS: Among the 75 patients successfully analyzed, 2 (2.5%) carried the CHEK2 1100delC allele. which was not significantly different (p = 0.26) from the 1% (3/300) carriers identified in the control group. CONCLUSION: In summary, our data suggest that the CHEK2 1100delC is not a major cause of double primary breast and colorectal cancer in Sweden, which suggests that this patient group should not routinely be screened for the CHEK2 1100delC variant
Diurnal rhythmicity in breast-milk glucocorticoids, and infant behavior and sleep at age 3 months
Purpose: In previous studies, associations between breast-milk cortisol levels obtained on one occasion and infant neurodevelopment were demonstrated. However, more recent evidence indicates that breast-milk cortisol and cortisone concentrations follow the diurnal rhythm of maternal hypothalamus-pituitary-adrenal axis, peaking in the early morning and with a nadir at midnight. We studied associations between breast-milk glucocorticoid (GC) rhythmicity, and infant behavior and sleep. Methods: We included 59 mothers, and their infants, of whom 17 had consulted an expert center during pregnancy for an increased risk of psychological distress. At 1 month postpartum, breast milk was sampled (on averag
Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features
About 5–10% of breast cancers are hereditary; a genetically and clinically heterogeneous disease in which several susceptibility genes, including BRCA1, have been identified. While distinct tumour features can be used to estimate the likelihood that a breast tumour is caused by a BRCA1 germline mutation it is not yet possible to categorize a BRCA1 mutated tumour. The aim of the present study is to molecularly classify BRCA1 mutated breast cancers by resolving gene expression patterns of BRCA1 and matched sporadic surgical breast tumour specimens. The expression profiles of 6 frozen breast tumour tissues with a proven BRCA1 gene mutation were weighed against those from 12 patients without a known family history but who had similar clinico-pathological characteristics. In addition two fibroblast cultures, the breast cancer cell-line HCC1937 and its corresponding B-lymphoblastoid cell line (heterozygous for mutation BRCA1 5382insC) and an epithelial ovarian cancer cell line (A2780) were studied. Using a high density membrane based array for screening of RNA isolated from these samples and standard algorithms and software, we were able to distinguish subgroups of sporadic cases and a group consisting mainly of BRCA1-mutated breast tumours. Furthermore this pilot analysis revealed a gene cluster that differentially expressed genes related to cell substrate formation, adhesion, migration and cell organization in BRCA1-mutated tumours compared to sporadic breast tumours. © 2001 Cancer Research Campaign http://www.bjcancer.co
- …